Inventor · disambiguated record
Mark William Surber
Also filed as: SURBER MARK · SURBER MARK W · SURBER MARK WILLIAM
37 granted patents·32 pending applications·431 citations·filing 2002–2025
98Inventor score
Files withAVALYN PHARMA INC23MPEX PHARMACEUTICALS INC6HORIZON ORPHAN LLC5SABBADINI ROGER A5VAXIION THERAPEUTICS INC5
Top patents by PatentIndex Score
69 records- 0197US7183105B2Eubacterial minicells and their use as vectors for nucleic acid delivery and expressionVAXIION THERAPEUTICS INC·Filed 2002·Granted Feb 27, 2007·90 cites·17 claims
- 0296US11559520B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Jan 24, 2023·4 cites·14 claims
- 0396US9670270B2Minicell based delivery of biologically active compoundsVAXIION THERAPEUTICS LLC·Filed 2015·Granted Jun 6, 2017·14 cites·17 claims
- 0496US9017986B2Minicell based delivery of biologically active compoundsVAXIION THERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·26 cites·18 claims
- 0596US8524484B2Immunogenic minicells and methods of useSABBADINI ROGER A·Filed 2012·Granted Sep 3, 2013·27 cites·7 claims
- 0695US11452718B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Sep 27, 2022·3 cites·15 claims
- 0795US10610536B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Granted Apr 7, 2020·5 cites·13 claims
- 0895US8129166B2Immunogenic minicells and methods of useSABBADINI ROGER A·Filed 2008·Granted Mar 6, 2012·19 cites·8 claims
- 0995US8101396B2Minicells displaying antibodies or derivatives thereof and comprising biologically active compoundsSABBADINI ROGER A·Filed 2007·Granted Jan 24, 2012·27 cites·3 claims
- 1094US11071741B2Aerosol pirfenidone and pyridone analog compound and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Jul 27, 2021·3 cites·15 claims
- 1194US8357696B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2010·Granted Jan 22, 2013·20 cites·43 claims
- 1294US7871815B2Rhamnose-inducible expression constructs and methodsVAXIION THERAPEUTICS INC·Filed 2006·Granted Jan 18, 2011·14 cites·2 claims
- 1394US7838532B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2006·Granted Nov 23, 2010·34 cites·84 claims
- 1493US10105356B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2013·Granted Oct 23, 2018·8 cites·14 claims
- 1592US10028966B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2017·Granted Jul 24, 2018·8 cites·13 claims
- 1692US8524734B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·13 cites·39 claims
- 1791US8815838B2Aerosol fluoroquinolone formulations for improved pharmacokineticsGRIFFITH DAVID C·Filed 2009·Granted Aug 26, 2014·18 cites·80 claims
- 1891US8546423B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Oct 1, 2013·12 cites·41 claims
- 1990US9717738B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2017·6 cites·29 claims
- 2090US8524735B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·10 cites·16 claims
- 2189US10092552B2Aerosol pirfenidone and pyridone analog compounds and uses thereofSURBER MARK WILLIAM·Filed 2012·Granted Oct 9, 2018·8 cites·11 claims
- 2289US7893020B2Bacterial efflux pump inhibitors and methods of treating bacterial infectionsMPEX PHARMACEUTICALS INC·Filed 2005·Granted Feb 22, 2011·13 cites·25 claims
- 2388US9326936B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·7 cites·17 claims
- 2487US11980689B2Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)AVALYN PHARMA INC·Filed 2020·Granted May 14, 2024·1 cites·12 claims
- 2587US10987357B2Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2019·Granted Apr 27, 2021·1 cites·13 claims
- 2687US7396822B2Immunogenic minicells and methods of useVAXIION THERAPEUTICS INC·Filed 2004·Granted Jul 8, 2008·12 cites·25 claims
- 2787US2025114376A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 2885US11224592B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Granted Jan 18, 2022·3 cites·10 claims
- 2985US9770443B2Aerosol pirfenidone and pyridone analog compounds and uses thereofGENOA PHARMACEUTICALS INC·Filed 2015·Granted Sep 26, 2017·5 cites·10 claims
- 3085US2025090463A1Inhaled imatinib for treatment of pulmonary arterial hypertension (pah)AVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 3184US11123290B2Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2019·Granted Sep 21, 2021·1 cites·16 claims
- 3284US10149854B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2017·Granted Dec 11, 2018·2 cites·20 claims
- 3384US7947741B2Use and administration of bacterial efflux pump inhibitorsMPEX PHARMACEUTICALS INC·Filed 2005·Granted May 24, 2011·8 cites·38 claims
- 3483US7994225B2Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infectionsREMPEX PHARMACEUTICALS INC·Filed 2007·Granted Aug 9, 2011·6 cites·17 claims
- 3582US10722519B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2018·Granted Jul 28, 2020·1 cites·10 claims
- 3682US7879795B2Enhancement of tigecycline potency using efflux pump inhibitorsMPEX PHARMACEUTICALS INC·Filed 2007·Granted Feb 1, 2011·2 cites·24 claims
- 3781US2025025415A1Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 3877US12023342B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2021·Granted Jul 2, 2024·0 cites·8 claims
- 3977US2025268821A1Nintedanib and nintedanib combination dry powder compositions and usesAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 4077US2025177294A1Nintedanib and nintedanib combination dry powder compositions and usesAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 4175US12226407B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·14 claims
- 4275US2022087937A1Aerosol tyrosine kinase inhibitor compounds and uses thereofAVALYN PHARMA INC·Filed 2021·Application pending·0 cites
- 4374US12090225B2Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2021·Granted Sep 17, 2024·0 cites·23 claims
- 4472US2021121472A1Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 4571US2019054076A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Application pending·0 cites
- 4670US2022218683A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2022·Application pending·0 cites
- 4769US2023201487A1Nebulizer device optimization for improved aerosol parameters and uses thereofAVALYN PHARMA INC·Filed 2023·Application pending·0 cites
- 4868US2009004744A1Minicells as vaccinesVAXIION THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4963US2014066441A1Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 5063US2023330357A1Nebulizer device optimization for improved aerosol parameters and uses thereofAVALYN PHARMA INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark William Surber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →